Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph W Franses

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|August 6, 2024
Spatially resolved immune drivers of HBV-associated HCC relapseIrun Bhan, Joseph W Franses
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2022
Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the PresentJoseph W Franses, Andrew X Zhu
Cancer Research|December 7, 2011
The evolution of endothelial regulatory paradigms in cancer biology and vascular repairJoseph W Franses, Elazer R Edelman
The Oncologist|October 12, 2018
In ReplyJoseph W Franses, David T Ting
Hepatology (Baltimore, Md.)|September 19, 2023
Scirrhous HCC: Another 'omic thread in the HCC tapestryJoseph W Franses, Dan G Duda
Gastroenterology|March 31, 2019
Has PD-1 MET Its Match in Hepatocellular Carcinoma?Joseph W Franses, Andrew X Zhu
JCO Precision Oncology|August 18, 2025
Limitations of Radiographic Response Assessments of Systemic Therapy for Advanced Hepatocellular CarcinomaKelsey S Lau-Min, Joseph W Franses
Med (New York, N.Y.)|May 19, 2022
PLSec: A novel, liquid biomarker for HCC riskJoseph W Franses, Irun Bhan, Andrew X Zhu
The Lancet. Gastroenterology & Hepatology|May 22, 2019
Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?Joseph W Franses, Theodore S Hong, Andrew X Zhu
Frontiers in Oncology|September 13, 2024
Targeted therapies in hepatocellular carcinoma: past, present, and futureRushabh Gujarathi, Joseph W Franses, Anjana Pillai, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|August 6, 2024
Spatially resolved immune drivers of HBV-associated HCC relapseIrun Bhan, Joseph W Franses
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2022
Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the PresentJoseph W Franses, Andrew X Zhu
Cancer Research|December 7, 2011
The evolution of endothelial regulatory paradigms in cancer biology and vascular repairJoseph W Franses, Elazer R Edelman
The Oncologist|October 12, 2018
In ReplyJoseph W Franses, David T Ting
Hepatology (Baltimore, Md.)|September 19, 2023
Scirrhous HCC: Another 'omic thread in the HCC tapestryJoseph W Franses, Dan G Duda
Gastroenterology|March 31, 2019
Has PD-1 MET Its Match in Hepatocellular Carcinoma?Joseph W Franses, Andrew X Zhu
JCO Precision Oncology|August 18, 2025
Limitations of Radiographic Response Assessments of Systemic Therapy for Advanced Hepatocellular CarcinomaKelsey S Lau-Min, Joseph W Franses
Med (New York, N.Y.)|May 19, 2022
PLSec: A novel, liquid biomarker for HCC riskJoseph W Franses, Irun Bhan, Andrew X Zhu
The Lancet. Gastroenterology & Hepatology|May 22, 2019
Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?Joseph W Franses, Theodore S Hong, Andrew X Zhu
Frontiers in Oncology|September 13, 2024
Targeted therapies in hepatocellular carcinoma: past, present, and futureRushabh Gujarathi, Joseph W Franses, Anjana Pillai, et al.
Pageof 4